Skip to main content Help with accessibility Skip to main navigation

SODIUM ZIRCONIUM CYCLOSILICATE powder for oral suspension (Lokelma®▼) for persistent hyperkalaemia

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 23 - Jun - 2022
Body System:
Amber initiated
SODIUM ZIRCONIUM CYCLOSILICATE powder for oral suspension (Lokelma®▼) for persistent hyperkalaemia

The Pan Mersey Area Prescribing Committee recommends the prescribing of SODIUM ZIRCONIUM CYCLOSILICATE powder for oral suspension (Lokelma®▼) for persistent hyperkalaemia in adults following initiation by a specialist in accordance with NICE TA599.

Static